Indivior PLC (INDV)
USD 9.44
(3.62%)
USD 9.44
(3.62%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -33.95 Million USD | 93.21% |
| 2022 | -499.68 Million USD | 38.64% |
| 2021 | -814.4 Million USD | -42.13% |
| 2020 | -572.99 Million USD | 25.29% |
| 2019 | -767 Million USD | -12.3% |
| 2018 | -682.99 Million USD | -79.27% |
| 2017 | -380.99 Million USD | -142.68% |
| 2016 | -156.99 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -50 Million USD | 80.96% |
| 2024 Q2 | -21 Million USD | -167.8% |
| 2024 Q1 | 30.97 Million USD | 191.24% |
| 2023 FY | -33.95 Million USD | 93.21% |
| 2023 Q4 | -33.95 Million USD | 89.8% |
| 2023 Q3 | -332.76 Million USD | -7.17% |
| 2023 Q2 | -310.49 Million USD | -0.74% |
| 2023 Q1 | -308.21 Million USD | 38.32% |
| 2022 Q1 | -590.49 Million USD | 27.49% |
| 2022 Q2 | -578.25 Million USD | 2.07% |
| 2022 Q3 | -544.85 Million USD | 5.78% |
| 2022 Q4 | -499.68 Million USD | 8.29% |
| 2021 Q4 | -814.4 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 107.799% |
| Embecta Corp. | 1.31 Billion USD | 102.588% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 136.04% |
| Dynavax Technologies Corporation | 106.63 Million USD | 131.839% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 107.402% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 107.846% |
| PainReform Ltd. | -7.95 Million USD | -327.069% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 145.3% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | -117.159% |
| SCYNEXIS, Inc. | -19.35 Million USD | -75.462% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | -260.053% |
| Cosmos Health Inc. | 8.59 Million USD | 495.215% |
| Journey Medical Corporation | -9.7 Million USD | -249.696% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | -117.159% |
| Safety Shot Inc | -2.28 Million USD | -1386.271% |
| Alpha Teknova, Inc. | 1.97 Million USD | 1819.959% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 74.049% |
| Bright Green Corporation | 1.84 Million USD | 1943.49% |
| Procaps Group, S.A. | 242.93 Million USD | 113.976% |
| Theratechnologies Inc. | 24.87 Million USD | 236.512% |
| Harrow Health, Inc. | 116.41 Million USD | 129.164% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | -1247.301% |
| Biofrontera Inc. | 4.05 Million USD | 937.081% |
| DURECT Corporation | -7.65 Million USD | -343.585% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | -1.268% |
| Cronos Group Inc. | -663.32 Million USD | 94.882% |
| OptiNose, Inc. | 58.06 Million USD | 158.472% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 105.446% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | -132.995% |
| RedHill Biopharma Ltd. | -5.18 Million USD | -554.682% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 326.151% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | -433.866% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | 31872.703% |
| Radius Health, Inc. | 359.28 Million USD | 109.45% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | 17316.249% |
| ProPhase Labs, Inc. | 19.23 Million USD | 276.548% |
| Phibro Animal Health Corporation | 454.84 Million USD | 107.465% |
| Procaps Group S.A. | 242.93 Million USD | 113.976% |
| Alvotech | 1.06 Billion USD | 103.19% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 1023.11% |
| Viatris Inc. | 17.13 Billion USD | 100.198% |
| Rockwell Medical, Inc. | 4.45 Million USD | 861.939% |
| Aytu BioPharma, Inc. | -4.87 Million USD | -596.166% |
| SIGA Technologies, Inc. | -148.68 Million USD | 77.165% |
| Tilray Brands, Inc. | 158.97 Million USD | 121.357% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 127.853% |
| Shineco, Inc. | 29.29 Million USD | 215.915% |
| PetIQ, Inc. | 351.93 Million USD | 109.647% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | -1070.182% |
| Incannex Healthcare Limited | -5.48 Million USD | -518.997% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 119.149% |
| Alimera Sciences, Inc. | 55.3 Million USD | 161.386% |
| Silver Spike Investment Corp. | -32.61 Million USD | -4.11% |
| Assertio Holdings, Inc. | -32.52 Million USD | -4.375% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | -2180.613% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | -570.937% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | -605.276% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | -313.369% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 905.122% |
| Hempacco Co., Inc. | 13.61 Million USD | 349.378% |
| Talphera, Inc. | -5.72 Million USD | -493.463% |
| Alvotech | 1.06 Billion USD | 103.19% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 575.185% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 64.893% |
| Currenc Group, Inc. | -16.57 Million USD | -104.862% |
| Kamada Ltd. | -46.43 Million USD | 26.877% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 13129.693% |
| Flora Growth Corp. | -713 Thousand USD | -4661.85% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | -313.369% |
| Evolus, Inc. | 63.7 Million USD | 153.293% |
| HUTCHMED (China) Limited | -197.45 Million USD | 82.805% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 107.086% |
| Akanda Corp. | 3.9 Million USD | 969.468% |